newsfilter
← Latest News
GlobeNewswire·

Albireo to Report Q4 and Year-End 2021 Financial Results on March 1

BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at 10:00 a.m. ET on M